bcl-2 immunoreactivity but not p53 accumulation associated with tumour response to radiotherapy in cervical carcinoma

Journal of Cancer Research and Clinical Oncology

Volumn 125, Issue 1, 1999, Pages 55-60

  Pillai, M R ^a   Jayaprakash, P G ^a   Nair, M Krishnan ^a  

^a REGIONAL CANCER CENTRE   (India)

Author keywords

bcl 2; Cervix; p53; Prognosis; Radiotherapy

Indexed keywords

FREE RADICAL; PROTEIN BCL 2; PROTEIN P53;

APOPTOSIS; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; DATA ANALYSIS; DNA DAMAGE; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; GENE EXPRESSION; GENE MUTATION; HUMAN; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RADIOSENSITIVITY; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA;

CELL NUCLEUS; CYTOPLASM; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; ODDS RATIO; PROTO-ONCOGENE PROTEINS C-BCL-2; TREATMENT OUTCOME; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS;

EID: 0032918330     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320050242     Document Type: Article

References (27)

1. Awwad S, Jaros E, Somes J, Lunec J (1996) p53 overexpression in head and neck carcinoma and radiotherapy results. Int J Radiation Oncol Biol Phys 34:323-332
2. Bristow RG, Benchimol S, Hill R (1996a) p53 protein expression or protein function? Int J Radiation Oncol Biol Phys 35:1123-1125
3. Bristow RG, Benchimol S, Hill RP (1996b) The p53 gene as a modifier of intrinsic radiosensitivity : implications for radiotherapy. Radiotherapy and Oncol 40:197-223
4. Chinnaiyan AM, Dixit VM (1996) The cell death machine. Curr Biol 6:555-562
5. Dewey WC, Ling CC, Meyn RE (1995) Radiation-induced apoptosis: relevance to radiotherapy. Int J Radiat Oncol Biol Phys 33:781-796
6. Ebara T, Mitsuhashi N, Saito Y, Sakurai H, Hasegawa M, Takahashi M, Takahashi T, Hayakawa R, Niibe H (1996) Prognostic significance of immunohistochemically detected p53 protein expression in stage IIIb squamous cell carcinoma of the uterine cervix treated with radiation therapy alone. Gynecol Oncol 63:216-218
7. Hunter RD, Cowie VJ, Blair V, Cole MP (1986) A clinical trial of two conceptually different radical radiotherapy treatments in stage III carcinoma of the cervix. Clin Radiol 37:23-27
8. Kesari AL, Chellam VG, Nair PP, Madhavan J, Nair MK, Pillai MR (1997) Expression of the antiapoptotic protein bcl-2 is not dependent on the tumour suppressor protein p53 in Indian breast carcinoma. Pathobiol 65:108-112
9. Kim HE, Han JS, Kasza T, Han R, Choi HS, Palmer KC, Kim CHR (1997) Platelet-derived growth factor (PDGF)-signaling mediates radiation-induced apoptosis in human prostate cancer cells with loss of p53 function. Int J Radiat Oncol Biol Phys 39:731-736
10. Kurvinen K, Tervahauta A, Syrjanen S, Chang F, Syrjanan K (1994) The state of the p53 gene in human papillomavirus (HPV)-positive and HPV-negative genital precancer lesions and carcinomas as determined by single-strand conformation polymorphism analysis and sequencing. Anticancer Res 14:177-181
11. Lakshmi S, Nair BS, Jayaprakash PG, Rajalekshmi TN, Nair MK, Pillai MR (1997) P53 protein and tumorigenesis in the uterine cervix. Gen Diagn Pathol 142:281-287
12. Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE, Housman DE, Jacks T (1994) p53 status and the efficacy of cancer therapy in vivo. Science 266:807-810
13. Morris GM (1996) Effects of radiation on the cell proliferation kinetics of epithelial tissues therapeutic implications. Bri J Radiol 69:795-803
14. Oka K, Nakano T, Arai T (1993) p53CMI expression is not associated with prognosis in uterine cervical carcinoma. Cancer 72:160-164
15. Pillai MR, Halabi S, McKalip A, Jayaprakash PG, Rajalekshmi TN, Nair MK, Herman B (1996) The presence of human pappilomavirus 16/18 E6, p53 and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer. Cancer Epidemiol Biomark Prevent 5:329-335
16. Pillai MR, Jayaprakash PG, Nair MK (1998a) Tumour proliferative fraction and growth factor expression as markers of tumour response to radiotherapy in cancer of the uterine cervix. J Cancer Res Clinical Oncol 124:456-461
17. Pillai MR, Kesari AL, Chellam VG, Madhavan J, Nair P, Nair MK (1998b) Spontaneous programmed cell death in infiltrating duct carcinomas of the breast. Pathol Res Pract 194:549-557
18. Pomp J, Davelaar J, Blom J, Krimpen CV, Zwinderman A. Quint W, Immerzeel J (1998) Radiotherapy for oesophagus carcinoma: the impact of p53 on treatment outcome. Radioth Oncol 46:179-184
19. Ravi D, Ramdas K, Mathew BS, Nalinakumari KR, Nair MK, Pillai MR (1998) Angiogenesis during tumor progression in the oral cavity is related to reduced apoptosis and high tumor cell proliferation. Oral Oncol (in press)
20. Raybaud-Diogene H, Fortin A, Morency R, Roy J, Monteil RA, Tetu B (1997) Markers of radioresistance in squamous cell carcinomas of the head and neck: a clinicopathologic and immunohistochemical study. J Clin Oncol 15:1030-1038
21. Sidransky D, Hollstein M (1996) Clinical implications of the p53 gene. Annu Rev Med 47:285-301
22. Srinivas G, Kusumakumary P, Nair MK, Panicker KR, Pillai MR (1998) Bcl-2 protein and apoptosis in pediatric acute lymphoblastic leukemia. Int J Mol Med 1:755-759
23. Stattin P, Damber JE, Modig H, Bergh A (1996) Pretreatment p53 immunoreactivity does not infer radioresistance in prostate cancer patients. Int J Radiat Oncol Biol Phys 35:885-889
24. Tan LKS, Ogden GR (1997) p53 over-expression in laryngeal carcinoma is not predictive of response to radiotherapy. Oral Oncol 33:177-181
25. West CML (1995) Intrinsic radiosensitivity as a predictor of patient response to radiotherapy. Bri J Radiol 68:827-837
26. Yang E, Korsmeyer SJ (1996) Molecular thanatopsis: a discourse on the bcl-2 family and cell death. Blood 88:386-401
27. Yarnold J (1997) Molecular aspects of cellular responses to radiotherapy. Radiother Oncol 44:1-7